Piramal   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Mumbai India (1988)
Status: No NME R&D (1988)

Organization Overview

First Clinical Trial
2005
NCT00407498
First Marketed Drug
1994
enflurane (ethrane)
First NDA Approval
2014
florbetaben F-18 (neuraceq)
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

LIFE MOLECULAR | Life Molecular Imaging GmbH | Nicholas Piramal Research Centre | Piramal Clinical Research (Hyderabad, India) | PIRAMAL CRITICAL | PIRAMAL ENT | Piramal Enterprises Limited | PIRAMAL HLTHCARE UK | Piramal Imaging GmbH | Piramal Imaging Limited | Piramal Imaging SA | Piramal Life Sciences | PIRAMAL PHARMA | Vice President- Clinical Research (R & D), Nicholas Piramal Research Centre | Wellquest Clinical Research